Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) Operating Income (2016 - 2025)

Historic Operating Income for CNL Healthcare Properties (CHTH) over the last 14 years, with Q3 2025 value amounting to $9.4 million.

  • CNL Healthcare Properties' Operating Income rose 1580.89% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year increase of 2895.36%. This contributed to the annual value of $30.9 million for FY2024, which is 12634.74% up from last year.
  • CNL Healthcare Properties' Operating Income amounted to $9.4 million in Q3 2025, which was up 1580.89% from $9.5 million recorded in Q2 2025.
  • CNL Healthcare Properties' Operating Income's 5-year high stood at $10.0 million during Q2 2024, with a 5-year trough of -$9.2 million in Q4 2021.
  • Moreover, its 5-year median value for Operating Income was $4.2 million (2021), whereas its average is $4.2 million.
  • As far as peak fluctuations go, CNL Healthcare Properties' Operating Income plummeted by 240300.75% in 2021, and later surged by 281047.62% in 2023.
  • Over the past 5 years, CNL Healthcare Properties' Operating Income (Quarter) stood at -$9.2 million in 2021, then soared by 108.67% to $797000.0 in 2022, then surged by 116.81% to $1.7 million in 2023, then skyrocketed by 270.14% to $6.4 million in 2024, then surged by 47.4% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q3 2025, $9.5 million for Q2 2025, and $8.5 million during Q1 2025.